Jeffrey W. Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), recently executed significant stock transactions, ...
Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp (NASDAQ:BPMC), recently executed a series of stock sales, according to a filing with the Securities and Exchange Commission. On ...
Kate Haviland, the Chief Executive Officer of Blueprint Medicines Corp (NASDAQ:BPMC), a biotechnology company with a market capitalization of $7.3 billion, has sold a portion of her holdings in the ...